Cargando…

Effect of antithrombin III on inflammatory immune response in patients with severe sepsis

Detalles Bibliográficos
Autores principales:	Inthorn, D, Hoffmann, JN, Hartl, WH, Mühlbayer, D, Jochum, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 1998
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301267/ http://dx.doi.org/10.1186/cc155

Ejemplares similares

Inhibition of endotoxin-induced leukocyte/endothelial cell interaction by antithrombin III
por: Hoffmann, JN, et al.
Publicado: (1999)

Effect of unfractionated and low molecular weight heparin on microcirculatory antithrombin effects during endotoxemia
por: Hoffmann, JN, et al.
Publicado: (2002)

Use of antithrombin III in cancer patients with sepsis complicated with disseminated intravascular coagulopathy
por: Polansky, M, et al.
Publicado: (1998)

Inhibition of neutrophil migration by the serpin antithrombin III
por: Dunzendorfer, S, et al.
Publicado: (2000)

Endotoxin-induced capillary perfusion failure and leukocyte adhesion is not prevented by the thrombin inhibitor hirudin: an intravital microscopic study
por: Hoffmann, JN, et al.
Publicado: (2000)

Specific deactivation of monocyte and lymphocyte migration by antithrombin III
por: Reinisch, C, et al.
Publicado: (2001)

HES 130 kD, but not crystalloid volume support reduces leukocyte–endothelial cell interaction during endotoxemia
por: Hoffmann, JN, et al.
Publicado: (2002)

Antibodies to beta(2)-glycoprotein I, prothrombin and antithrombin III as markers of the antiphospholipid syndrome severity
por: Zabek, J, et al.
Publicado: (2001)

Antithrombin III (AT III) prevents increased permeability and leukocyte adhesion in response to endotoxin (LPS) in the microcirculation of rat mesentery
por: Leithäuser, B, et al.
Publicado: (1999)

Decreased Protein C, Protein S and Antithrombin III Levels are predictive of poor outcome in Gram-negative sepsis caused by Burkholderia pseudomallei
por: Larosa, SP, et al.
Publicado: (2000)

Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory markers: a preliminary report
por: Giarratano, A, et al.
Publicado: (2000)

Distinct antithrombin III preparations deactivate IL-8-induced neutrophil chemotaxis with different potency
por: Kaneider, N, et al.
Publicado: (2001)

G-protein- and phosphodiesterase-dependent regulation of neutrophil migration by antithrombin III involving CXC-receptor 1
por: Dunzendorfer, S, et al.
Publicado: (2000)

Effects of Antithrombin III on body cavity effusions, fluid balance, colloid osmotic pressure and hemodynamics in porcine septic shock
por: Cobas Meyer, M, et al.
Publicado: (2000)

Inhibition of proliferation and induction of differentiation of endothelial cells by antithrombin
por: Reinisch, CM, et al.
Publicado: (2002)

Lipopolysaccharides-induced interleukin-8 production is inhibited by antithrombin
por: Gray, E, et al.
Publicado: (2001)

Antithrombin (AT) improves inflammation induced microcirculatory disturbance in rat mesentery
por: Leithäuser, B, et al.
Publicado: (2000)

Lipopolysaccharide induced procoagulant activity and cytokine production: influence of antithrombin
por: Gray, E, et al.
Publicado: (2000)

Antithrombin prevents proinflammatory activation via NFκ and MAPK signaling pathways
por: Oelschläger, C, et al.
Publicado: (2002)

Syndecan-4 on human peripheral blood lymphocytes and monocytes mediates effects of antithrombin on chemotaxis
por: Kaneider, NC, et al.
Publicado: (2002)

Antithrombin III concentrate therapy may have an efficacy in sepsis
por: Saito, N, et al.
Publicado: (2013)

The Association between the Level of Antithrombin III and Mortality in Children with Sepsis
por: Lestari, Indah Nur, et al.
Publicado: (2019)

Antithrombin in sepsis revisited
por: Levi, Marcel
Publicado: (2005)

Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?
por: Hoffmann, Johannes N, et al.
Publicado: (2007)

Effect of antithrombin III (AT) on lipopolysaccharide (LPS)-induced production of tissue factor and interleukin-6 (IL-6) by human umbilical vein endothelial cells (HUVECs), mononuclear cells (MNCs) and whole blood
por: Souter, PJ, et al.
Publicado: (1999)

Potential of antithrombin III as a biomarker of antidepressive effect in major depressive disorder
por: Song, R., et al.
Publicado: (2021)

Marked reductions of protein C and antithrombin in post-trauma DIC have close relations with MODS and poor outcome
por: Gando, S, et al.
Publicado: (2002)

Reduction of D-dimer levels after therapeutic administration of antithrombin in acquired antithrombin deficiency of severe sepsis
por: Kountchev, Jordan, et al.
Publicado: (2005)

Complement activation in relation to age in patients with severe sepsis
por: Marx, G, et al.
Publicado: (2002)

A new diagnostic and severity marker in patients with SIRS, sepsis, severe sepsis and septic shock; procalcitonin
por: Çelebi, S, et al.
Publicado: (2000)

Antithrombin III concentrate may contribute to sepsis in nonovert disseminated intravascular coagulation
por: Saito, Noriko, et al.
Publicado: (2013)

Antithrombin III expression predicts acute kidney injury in elderly patients with sepsis
por: Xie, Yun, et al.
Publicado: (2020)

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock
por: Brunkhorst, FM, et al.
Publicado: (1999)

Antithrombin reduces the ischemia/reperfusion-induced hepatic injury by increasing hepatic levels of prostacyclin through activation of capsaicin-sensitive sensory neurons in rats
por: Harada, N, et al.
Publicado: (2002)

Antithrombin substitution before extracorporeal circulation attenuates perioperative coagulation activation and might decrease postoperative troponin elevation: a report of preliminary data
por: Busley, R, et al.
Publicado: (2003)

Antithrombin and free tri-iodothyronine in sepsis
por: Mateu, P, et al.
Publicado: (2004)

Are IL-6, IL-10 and PCT plasma concentrations more reliable than APACHE-III or SAPS-II for the individual mortality risk prediction in severe sepsis?
por: Müller, C, et al.
Publicado: (2000)

Deficiency Of Antithrombin III (AT III) - Case Report and Review of the Literature
por: GĂMAN, AMELIA MARIA, et al.
Publicado: (2014)

Steroid hormone synthesis is impaired in patients with severe sepsis
por: Angstwurm, M, et al.
Publicado: (2003)

Quality of life in ICU survivors with severe sepsis who received activated protein C
por: Cook, WT, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_shhr7iomfeqvi9m4h5u7dmbf09